FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 17 filers reported holding FREELINE THERAPEUTICS HLDGS in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $75 | +476.9% | 162,214 | +511.2% | 0.00% | – |
| Q4 2022 | $13 | -100.0% | 26,540 | -55.5% | 0.00% | – |
| Q2 2021 | $486,000 | -40.9% | 59,638 | -10.8% | 0.00% | -100.0% |
| Q1 2021 | $822,000 | -37.5% | 66,851 | -7.2% | 0.00% | 0.0% |
| Q4 2020 | $1,316,000 | -32.2% | 72,056 | -42.1% | 0.00% | -50.0% |
| Q3 2020 | $1,942,000 | – | 124,431 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,466,508 | $3,783,591 | 5.70% |